We are live on
!
Find out more
First Trust Advisors Portfolio holdings
AUM
$170B
1-Year Est. Return
46.21%
This Fund
S&P 500
This Quarter
Est. Return
+7.26%
1 Year Est. Return
+46.21%
3 Year Est. Return
+117.8%
5 Year Est. Return
+135.17%
10 Year Est. Return
+586.77%
AUM
$29.6B
AUM Growth
+$4.22B
(+17%)
Cap. Flow
+$2.91B
Cap. Flow
% of AUM
9.83%
Top 10 Holdings %
Top 10 Hldgs %
7.91%
Holding
2,390
New
174
Increased
1,221
Reduced
844
Closed
147
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF
HYLS
|
+$184M |
| 2 |
First Trust NYSE Arca Biotechnology Index Fund
FBT
|
+$158M |
| 3 |
First Trust Health Care AlphaDEX Fund
FXH
|
+$136M |
| 4 |
First Trust Dow Jones Internet Index Fund ETF
FDN
|
+$123M |
| 5 |
First Trust Consumer Staples AlphaDEX Fund
FXG
|
+$123M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$120M |
| 2 |
Conagra Brands
CAG
|
+$72.2M |
| 3 |
IMGN
Immunogen Inc
IMGN
|
+$61.5M |
| 4 |
RAD
Rite Aid Corporation
RAD
|
+$55.9M |
| 5 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
+$50.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.01% |
| 2 | Technology | 13.69% |
| 3 | Consumer Discretionary | 10.39% |
| 4 | Miscellaneous | 10.14% |
| 5 | Consumer Staples | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MIG
1626
DELISTED
MEADOWBROOK INSURANCE GRP INC
MIG
| $1.35M | ﹤0.01% |
+159,449
| New | +$1,000K |
|
|
JNS
1627
DELISTED
Janus Capital Group Inc
JNS
| $1.35M | ﹤0.01% |
83,588
-128,336
| -61% | -$1.93M |
|
|
CKP
1628
DELISTED
CHECKPOINT SYSTEMS INC
CKP
| $1.34M | ﹤0.01% |
97,996
+74,336
| +314% | +$961K |
|
1629
Cathay General Bancorp
CATY
$4.13B
| $1.34M | ﹤0.01% |
52,525
+9,119
| +21% | +$231K |
|
1630
Independent Bank
INDB
$3.91B
| $1.34M | ﹤0.01% |
31,274
+3,109
| +11% | +$123K |
|
1631
Tootsie Roll Industries
TR
$2.91B
| $1.33M | ﹤0.01% |
61,908
+10,803
| +21% | +$221K |
|
1632
PetMed Express
PETS
$38.2M
| $1.33M | ﹤0.01% |
92,539
-13,110
| -12% | -$177K |
|
|
ZEP
1633
DELISTED
ZEP INC COM STK (DE)
ZEP
| $1.33M | ﹤0.01% |
87,557
+11,591
| +15% | +$171K |
|
|
NPKI
1634
NPK International
NPKI
$1.15B
| $1.32M | ﹤0.01% |
138,697
+38,033
| +38% | +$404K |
|
1635
Rollins
ROL
$16.8B
| $1.32M | ﹤0.01% |
+134,679
| New | +$1.26M |
|
1636
Digi International
DGII
$2.65B
| $1.31M | ﹤0.01% |
141,573
+23,275
| +20% | +$184K |
|
|
ORB
1637
DELISTED
ORBITAL SCIENCES CORP
ORB
| $1.31M | ﹤0.01% |
48,823
-33,521
| -41% | -$885K |
|
1638
Boston Beer
SAM
$1.67B
| $1.31M | ﹤0.01% |
4,528
+2,231
| +97% | +$565K |
|
1639
Boise Cascade
BCC
$2.68B
| $1.31M | ﹤0.01% |
35,145
+15,745
| +81% | +$542K |
|
1640
Flowers Foods
FLO
$1.34B
| $1.3M | ﹤0.01% |
67,804
-650,983
| -91% | -$12.3M |
|
1641
SunCoke Energy
SXC
$868M
| $1.3M | ﹤0.01% |
67,221
+42,948
| +177% | +$901K |
|
1642
First Industrial Realty Trust
FR
$8.18B
| $1.3M | ﹤0.01% |
63,176
+15,612
| +33% | +$301K |
|
1643
Bio-Rad Laboratories Class A
BIO
$10.2B
| $1.29M | ﹤0.01% |
10,717
-80,661
| -88% | -$9.28M |
|
1644
Forrester Research
FORR
$232M
| $1.29M | ﹤0.01% |
32,799
+13,985
| +74% | +$555K |
|
1645
First Trust Large Cap Growth AlphaDEX Fund
FTC
$1.33B
| $1.29M | ﹤0.01% |
27,791
-11,172
| -29% | -$501K |
|
1646
Crown Holdings
CCK
$12.3B
| $1.29M | ﹤0.01% |
25,307
-212,115
| -89% | -$10.2M |
|
|
GK
1647
DELISTED
G&K Services Inc
GK
| $1.29M | ﹤0.01% |
18,146
-14,022
| -44% | -$889K |
|
1648
Emergent Biosolutions
EBS
$308M
| $1.28M | ﹤0.01% |
47,150
+1,190
| +3% | +$28.4K |
|
1649
The Ensign Group
ENSG
$9.94B
| $1.28M | ﹤0.01% |
61,730
-130,303
| -68% | -$2.39M |
|
1650
Medifast
MED
$136M
| $1.28M | ﹤0.01% |
38,148
-37,571
| -50% | -$1.17M |
|
Similar funds
First Trust Advisors's Q4 2014 Portfolio in Review
As of Q4 2014, First Trust Advisors held 2,390 positions worth $29.6B, up 17% from $25.4B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
First Trust Advisors deployed $2.91B of net new capital in Q4 2014, opening 174 new positions and adding to 1,221 existing holdings. Its largest new stake was Alnylam Pharmaceuticals: 857,683 shares worth $83.2M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $120M trimmed.
- First Trust Advisors's largest Q4 2014 buy was Alnylam Pharmaceuticals: 857,683 shares worth $83.2M.
- First Trust Advisors added most to First Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF in Q4 2014, an estimated $184M increase.
- First Trust Advisors's biggest Q4 2014 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $120M.
- First Trust Advisors fully exited Immunogen Inc in Q4 2014, selling an estimated $61.5M.
- First Trust Advisors's ten largest holdings make up 7.9% of its $29.6B portfolio in Q4 2014.
- First Trust Advisors opened 174 new positions and closed 147 in Q4 2014.
- First Trust Advisors's portfolio value rose 17% quarter-over-quarter to $29.6B.
Based on First Trust Advisors's 13F filing for Q4 2014, filed 13 Feb 2015.